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Abstract
Background:  Clearance of synaptically released glutamate, and hence termination of
glutamatergic neurotransmission, is carried out by glutamate transporters, most especially
glutamate transporter-1 (GLT-1) and the glutamate-aspartate transporter (GLAST) that are
located in astrocytes. It is becoming increasingly well appreciated that changes in the function and
expression of GLT-1 and GLAST occur under different physiological and pathological conditions.
Here we investigated the plasticity in expression of GLT-1 and GLAST in the spinal dorsal horn
using immunohistochemistry following partial sciatic nerve ligation (PSNL) in rats.
Results: Animals were confirmed to develop hypersensitivity to mechanical stimulation by 7 days
following PSNL. Baseline expression of GLT-1 and GLAST in naive animals was only observed in
astrocytes and not in either microglia or neurons. Microglia and astrocytes showed evidence of
reactivity to the nerve injury when assessed at 7 and 14 days following PSNL evidenced by
increased expression of OX-42 and GFAP, respectively. In contrast, the total level of GLT-1 and
GLAST protein decreased at both 7 and 14 days after PSNL. Importantly, the cellular location of
GLT-1 and GLAST was also altered in response to nerve injury. Whereas activated astrocytes
showed a marked decrease in expression of GLT-1 and GLAST, activated microglia showed de novo
expression of GLT-1 and GLAST at 7 days after PSNL and this was maintained through day 14.
Neurons showed no expression of GLT-1 or GLAST at any time point.
Conclusion: These results indicate that the expression of glutamate transporters in astrocytes
and microglia are differentially regulated following nerve injury.
Background
Glutamate is the major excitatory neurotransmitter in the
mammalian central nervous system (CNS), including the
spinal dorsal horn[1]. It has been implicated in the gener-
ation and maintenance of hypersensitivity after tissue
inflammation and injury [2]. Under normal physiological
conditions, glutamate is released from the presynaptic
membrane, and acts on glutamate receptors at the postsy-
naptic membrane, including N-methyl-D-aspartate
(NMDA), a-amino-3-hydroxy-5-methyl-4-isoxazolepro-
Published: 26 March 2009
Molecular Pain 2009, 5:15 doi:10.1186/1744-8069-5-15
Received: 1 December 2008
Accepted: 26 March 2009
This article is available from: http://www.molecularpain.com/content/5/1/15
© 2009 Xin et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Molecular Pain 2009, 5:15 http://www.molecularpain.com/content/5/1/15
Page 2 of 8
(page number not for citation purposes)
pionic acid (AMPA), and metabotropic glutamate recep-
tors, resulting in cation influx and depolarization of the
postsynaptic membrane [3]. Excessive glutamate results in
an overload of Ca2+ influx that can result in excitotoxicity
and ultimately death of neurons. Inhibitory interneurons
have been suggested as particularly vulnerable to excito-
toxic damage [4].
The concentration of extracellular glutamate is tightly reg-
ulated by a family of high affinity Na+-dependent gluta-
mate transporters in the cytoplasmic membrane of glial
cells and to lesser extent in neurons [5,2,6]. A total of five
glutamate transporters have been cloned and character-
ized. Among these, GLT-1 and GLAST are the major gluta-
mate transporters in the CNS, and are mainly expressed in
astrocytes [5,7-9]. Astrocytes metabolize the sequestered
glutamate to glutamine using the enzyme glutamine syn-
thetase and shuttle the newly synthesized glutamine back
into neurons where it can be reconverted to glutamate
[10].
Accumulating data indicate that dysfunction in glutamate
transport produces marked changes in spinal processing
of nociceptive inputs. Inhibition of glutamate transport-
ers causes an elevation in spinal extracellular glutamate
concentrations and produces spontaneous nociceptive
behaviors and hypersensitivity to mechanical and thermal
stimuli [11,12]. Deficiency and down-regulation of GLT-1
or GLAST in the spinal dorsal horn has been associated
with the development of neuropathic pain induced by
peripheral nerve injury [13,14] or chemotherapy [15]. It
remains unclear however, whether transporter expression
and function are differentially regulated in different spinal
cell types. This issue was explored in this study by exami-
nation of changes in the expression and cellular localiza-
tion of GLT-1 and GLAST in the spinal dorsal horn over
time following partial sciatic nerve ligation (PNSL).
Results
Behavioral Findings
Consistent with previous results [16,17], the paw ipsilat-
eral to the PSNL developed significant mechanical hyper-
sensitivity as compared to the control side and to control
rats. The paw withdrawal thresholds on the ipsilateral side
were significantly decreased at 7 (4.6 ± 0.96 g) and 14
days (4.3 ± 1.12 g) after PSNL, compared with the control
group (12.6 ± 3.84 g).
PSNL induces activation of astrocytes in the spinal dorsal 
horn
Glial fibrillary acidic protein (GFAP) immunoreactivity
(IR) in the dorsal horn ipsilateral to the nerve injury
showed a noticeable increase by 1 day after PSNL (Figure
1B) compared with the control group (Figure 1A). This
became more pronounced by day 7 and 14 after injury
(Figure 1C, Figure 1D).
GLT-1 and GLAST expression decreases in spinal 
astrocytes following PSNL
The expression of GLT-1 and GLAST in the spinal dorsal
horn in naïve animals were mainly expressed in the gray
matter of the spinal cord, especially in the superficial lam-
inae (Figure 2A, Figure 3A). Double staining results
showed that both GLT-1 and GLAST were colocalized with
the astrocytic marker GFAP (Figure 4D, 4E, 4F and Figure
5D, 5E, 5F), but not with the neuronal marker NeuN (Fig-
ure 4A, 4B, 4C and Figure 5A, 5B, 5C) or the microglia
marker OX-42 (Figure 4G, 4H, 4I and Figure 5G, 5H, 5I).
The expression of GLT-1 was significantly decreased in the
ipsilateral spinal dorsal horn at 7(p < 0.01) and 14 days
(p < 0.01) after PSNL (Figure 2C, 2D) compared with con-
trols (Figure 2A). Semiquantitative analyses showed that
the relative intensity of GLT-1 decreased by 42 ± 15.79%
at 7 days and 32.3 ± 13.13% at 14 days following injury,
respectively, when compared to the control group (Figure
2E). Similarly, the expression of GLAST was reduced by 54
± 22.13% at 7 days and by 42 ± 16.34% at 14 days after
nerve injury (Figure 3C, 3D, 3E). Decreases in the expres-
sion of GLT-1 and GLAST were also found significant in a
side to side comparison of the contralateral versus ipsilat-
eral sides of the spinal cord within the PNSL animals (Fig-
ure 2E and Figure 3E). However, the total amount of GLT-
1 and GLAST one day after ligation did not change. The
results from the above suggest that the decrease in GLT-1
and GLAST, which was induced by PNSL, mainly occurred
in astrocytes on the injured side.
GFAP-immunoreactivity was increased after PSNL Figure 1
GFAP-immunoreactivity was increased after PSNL. 
A-D: GFAP-immunoreactive staining was significantly 
increased in spinal dorsal horn 1 day (B), 7 days (C) and 14 
days (D) after PNSL compared to the control group (A). 
Scale bar: (A-D) = 20 μm.Molecular Pain 2009, 5:15 http://www.molecularpain.com/content/5/1/15
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Activation of microglia following PSNL
Microglia in the spinal horn also showed evidence of acti-
vation due to the PSNL. An increase in OX-42-positive
cells were noted by day 1 post PSNL (Figure 6B) compared
with the control group (Figure 6A). The increase in OX-42
appeared to reach a maximum on day 7 after nerve injury
(Figure 6C) and maintained this elevated level through
day 14 after PSNL (Figure 6D).
Upregulation of GLT-1 and GLAST in microglia following 
PSNL
As noted above, there was no co-localization of GLT-1 or
GLAST with OX-42 positive microglia in the absence of
nerve injury. By day 7 post PSNL double staining showed
that OX-42-positive cells (Figure 4O) showed a de novo
up-regulation of GLT-1that persisted through day 14 post
PSNL (Figure 5S). Likewise, GLAST-positive OX-42 posi-
tive cells were observed at both days 7 (Figure 4O) and 14
post PNSL (Figure 4S). Quantitative analysis of the inten-
sity of co-labeling for the glutamate transporters with
GFAP and OX-42 over time is shown in Figure 7. Signifi-
cant decreases in double label intensity for both GLT-1
and GLAST with GFAP were found at days 7 and 14 fol-
lowing PSNL. The opposite was found for GLT-1 and
GLAST co-localization with OX-42 with both showing
increases at days 7 and 14 following PNSL. Finally, no co-
localization of either GLT-1 or GLAST was found in NeuN
positive cells (neurons) at any time point (Figure 8D, E).
Discussion
The results of this study demonstrate plasticity not only in
the expression levels but also in the cellular localization of
The expression of GLT-1 was reduced after PSNL Figure 2
The expression of GLT-1 was reduced after PSNL. A-D: The results of immunohistochemmistry show that GLT-1 
immunoreactivity decreased in the ipsilateral dorsal horn 7 days (C) and 14 days (D) after PNSL compared to the control 
group (A), However, the total amount of GLT-1 1 day after ligation did not change (B). E: Ratio (black bars) of the relative 
intensity between the ipsilateral sides of the variable groups (1 day, 7 days, and 14 days) and the control group as well as ratio 
(white bars) of the relative intensity between the ipsilateral and contralateral sides of the same variable groups (n = 5/group). 
Scale bar: (A-D) = 500 μm.Molecular Pain 2009, 5:15 http://www.molecularpain.com/content/5/1/15
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the glutamate transporters GLT-1 and GLAST following
partial sciatic nerve ligation. Staining of GLT-1 and GLAST
was found in the spinal dorsal horn at baseline. GLT-1
and GLAST were not co-localized with the microglia
marker OX-42 or the neuron marker NeuN at baseline,
but rather only in cells positive for the astrocyte marker
GFAP. This suggests that the expression of GLT-1 and
GLAST under normal conditions in the spinal dorsal horn
primarily originates in astrocytes. This conclusion is con-
sistent with reports on the distribution of GLT-1 and
GLAST in hippocampus and cerebellum where the trans-
porters were found to be in astrocytes [18-21].
Nerve injury was found to result in a decrease in the total
amount of GLT-1 and GLAST at 7 and 14 days after PSNL.
The clear implication from the double-labeling study is
that the synthesis of the transporters is down-regulated in
astrocytes after PSNL. This result is consistent with other
reports. For example, the total amount of GLT-1 decreased
after facial nerve axotomy [22] and with spinal nerve
injury [23]. Another line of investigation has shown that
glutamate uptake is attenuated in spinal dorsal in rat after
complete spinal nerve ligation [14]. Decreases in GLT-1
and GLAST transporters and an ensuing accumulation of
glutamate in the synaptic cleft is consistent with neuro-
The expression of GLAST was decreased after PSNL Figure 3
The expression of GLAST was decreased after PSNL. A-D: Immunohistochemistry analysis reveals that GLAST was 
reduced in the ipsilateral dorsal horn 7 days (C) and 14 days (D) after PNSL compared to the normal group (A), However, no 
change was seen in the total amount of GLAST 1 day after ligation (B). E: Ratio (black bars) of the relative intensity between 
the ipsilateral sides of the variable groups (1 day, 7 days, and 14 days) and the control group as well as ratio (white bars) of the 
relative intensity between the ipsilateral and contralateral sides of the same variable groups (n = 5/group). Scale bar: (A-D) = 
500 μm.Molecular Pain 2009, 5:15 http://www.molecularpain.com/content/5/1/15
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physiological studies of spinal neurons following nerve
injury [24] wherein an excess of afterdischarges was noted
as a cardinal feature. Conversely, gene transfer of GLT-1
into spinal cord attenuates inflammatory and neuropathic
pain in rats [25]
Evidence of activation of spinal glia cells shown here by
the increases in GFAP and OX-42 staining density is also
consistent with previous reports [26-28]. An important
implication from this work is that activated astrocytes evi-
dently shift homeostatic functions upon exposure to
nerve injury and part of this shift involves decreased regu-
lation of synaptic functions evidenced by down-regula-
tion of glutamate transporters. The mechanism by which
astrocytes become activated remains an area of needed
investigation. Potential signals may include central release
of fractalkine or other growth factors [28]. Activation of
spinal astrocytes appears to coincide with the initiation of
re-growth of injured axons [29], which suggests that per-
haps the shift in astrocyte function is to support the
growth of central axons of primary afferent fibers that are
in the process of re-generating across the lesion site. Evi-
dence to support this possibility is that growth related
antigens such as growth associated protein-43 and endog-
enous lectin RL-29 show peaks in the dorsal horn at the
same time points where peaks in re-generating axons are
found in injured nerve roots [30-33].
A novel finding from this work is the observation that
PNSL-activated microglia initiate a new expression of
GLT-1 and GLAST. In agreement with this observation,
GLT-1 was observed as newly expressed in scattered
microglia in an astrocyte-neuron culture [34]. This finding
suggests that as astrocytes shift to support re-growth and
the establishment of re-connectivity, that microglia
assumes the role of regulating synaptic function.
Finally, no expression or change in expression of GLT-1 or
GLAST was observed in neurons. The expression of the
Activated microglia expressed GLT-1 after PNSL Figure 4
Activated microglia expressed GLT-1 after PNSL. A-
I: Under normal conditions, the expression of GLT-1 was 
found in astrocytes (D-F), but not neurons (A-C) or micro-
glia (G-I). After PSNL, microglia displayed an apparent 
increase in both amount and size when compared to the nor-
mal group (G, J, M, P). M-S: Microglia showed co-localization 
with GLT-1 antibody-positive cell in 7 (M-O) and 14 days (P-
S) after PSNL, but not at 1 day after PSNL (J-L). Scale bar: (A-
S) = 50 μm.
OX-42 positive cells expressed the GLAST after PNSL Figure 5
OX-42 positive cells expressed the GLAST after 
PNSL. A-I: Under normal conditions, the expression of 
GLAST was found in astrocytes (D-F), but not neurons (A-C) 
or microglia (G-I). After PSNL, microglia displayed an 
increase in both amount and size when compared to the nor-
mal group (G, J, M, P). M-S: The microglia was co-localized 
with GLAST antibody-positive cell in 7 (M-O) and 14 days (P-
S) after PSNL, but not at 1 day after PSNL (J-L). Scale bar: (A-
S) = 50 μm.Molecular Pain 2009, 5:15 http://www.molecularpain.com/content/5/1/15
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neuronal glutamate transporter EAAC1 was not explored
here. Hence the potential for plasticity in this expression
remains open to investigation.
Conclusion
This paper provides evidence that not only the expression
but also the cellular localization of the glutamate trans-
porters changed following PSNL. Under baseline physio-
logical conditions, the expression of GLT-1 and GLAST in
the spinal dorsal horn is confined to astrocytes. After
PSNL, spinal glial cells show evidence of activation, the
expression of GLT-1 and GLAST are decreased, and the
decreases occur in the astrocytes. Microglia activated fol-




A total of 46 male Sprague-Dawley rats weighing 180–220
g were used. All experiments were conducted with the
approval of the Institutional Animal Care and Use Com-
mittee at the M.D. Anderson Cancer Center and were in
compliance with the National Institutes of Health Guide-
lines for Use and Care of Laboratory Animals. The mini-
mum number of animals was used in each experiment,
and in all cases every effort was made to minimize any
pain or suffering in the subject animals.
Surgical procedure
Rats were anesthetized with 50 mg/kg (i.p.) of pentobar-
bital and the left sciatic nerve was exposed at the high
thigh level. Partial sciatic nerve ligation was performed as
previously described [16,17]. Briefly, one-third to one-
half of the left sciatic nerve was tightly ligated using 7-0
silk suture. Sham surgery in age matched animals con-
sisted of exposing the left sciatic nerve but no ligation was
Neither GLT-1 antibody-positive cells, nor GLAST antibody- positive cells co-localized with the NeuN-positive cells (Fig- ure 7A) Figure 8
Neither GLT-1 antibody-positive cells, nor GLAST 
antibody-positive cells co-localized with the NeuN-
positive cells (Figure 7A). A-C: The NeuN-positive cells 
did not show any expression of GLT-1 1 day (A), 7 days (B) 
and 14 days (C) after PSNL. D-F: The NeuN-positive staining 
is not co-localized with the GLAST antibody-positive cells 1 
day (D), 7 days (E) or14 days (F) after PSNL. Scale bar: (A-F) 
= 50 μm.
The bar graphs show the intensity of double label fluores- cence for GLT1-OX-42 (black bars), GLAST-OX-42 (open  bars), GLT1-GFAP (gray bars), and GLAST-GFAP (cross- hatched bars) Figure 7
The bar graphs show the intensity of double label flu-
orescence for GLT1-OX-42 (black bars), GLAST-
OX-42 (open bars), GLT1-GFAP (gray bars), and 
GLAST-GFAP (cross-hatched bars). The intensity of 
double label of both glutamate transporters with GLT1 was 
significantly increased at days 7 and 14 following PSNL, 
whereas the intensity of double label for both transporters 
with GFAP was significantly decreased at these same time 
points. *** = p < 0.001.
Microglia were activated after PSNL Figure 6
Microglia were activated after PSNL. A-D: OX-42-
positve cells were increased in spinal dorsal horn 1 day (B), 7 
days (C) and 14 days (D) after PSNL compared to the con-
trol group (A). Scale bar: (A-D) = 50 μm.Molecular Pain 2009, 5:15 http://www.molecularpain.com/content/5/1/15
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made. The muscle layers were closed with 4-0 silk and the
skin sealed with surgical clips.
Behavioral testing
The rats were accommodated to the testing environment
by placement within testing chambers for 15–20 min on
the three separate days just prior to the pre-operative test-
ing. Mechanical sensitivity was assessed using von Frey
hairs as described previously[35]. Briefly, rats were placed
under separate transparent Plexiglas chambers positioned
on a wire mesh floor. Fifteen minutes were allowed for
habituation. Each stimulus consisted of a 2–3 s applica-
tion of the von Frey hair to the middle of the plantar sur-
face of the foot with 5 min interval between stimuli. Brisk
withdrawal or licking of the paw following the stimulus
was considered a positive response. The experimenter
who conducted the behavioral tests was blinded to all
treatments.
Immunohistochemistry
Rats were deeply anesthetized with urethane (1.5 g/kg,
i.p.) at 1, 7 or 14 days following nerve injury, the chest
opened, and then quickly perfused through the ascending
aorta with warm heparinized saline, followed by 4% para-
formaldehyde in 0.1 M phosphate buffer, pH 7.2–7.4,
4°C. The L4–L5 spinal segments were removed and post-
fixed for 3 h in the same fixative, and then stored in 30%
sucrose overnight. Transverse sections (25 μm) were cut
by cryostat and processed for immunohistochemical
staining as previously described [36]. Sections were
blocked with 3% donkey serum in 0.3% Triton X-100 for
1 hour at room temperature then incubated overnight at
4°C with guinea pig anti-GLT-1 antibody (1:2000,
Chemicon) or rabbit anti-GLAST antibody (1:250,
Abcam). The sections were then incubated for 1 h at room
temperature with FITC-conjugated secondary antibody
(1:250, Chemicon) or Cy3-conjugated secondary anti-
body (1:500, Chemicon). For double immunofluores-
cence, the spinal sections were incubated with a mixture
of guinea anti-GLT1 antibody or rabbit anti-GLAST anti-
body and mouse anti-neuronal nuclei (NeuN, neuronal
marker, 1:500, Chemicon), mouse anti-glial fibrillary
acidic protein (GFAP, Astrocyte marker, 1:500, Chemi-
con) or mouse anti-OX-42 (Microglia marker, 1:500,
Chemicon) antibody overnight at 4°C. Afterwards the sec-
tions were incubated with a mixture of FITC- and Cy3-
conjugated secondary antibodies for 1 h at a room tem-
perature. The stained sections were then examined with a
Nikon E600 (Nikon Instech Co, Japan) fluorescence
microscope and images were captured with a CCD spot
camera.
Statistical analysis
The relative intensity of GLT-1-IR and GLAST-IR per sec-
tion was measured in the spinal dorsal horn using a com-
puterized image analysis system (NIS-Elements, BR 2.30).
An optic threshold was set above background level firstly
to identify positively stained structures. Relative intensity
values used for comparison were calculated by multiply-
ing the mean optic density in areas of interest and then
subtracting out background staining (mean optic density
* positive area – value of background). In each rat, four to
six sections of the spinal cord at each time point were
selected randomly. An average percentage of GLT-1-IR,
GLT-1 + OX-42-IR, GLT-1 + GFAP-IR, GLAST-IR, GLAST +
OX-42-IR, and GLAST + GFAP-IR relative to the control
group, was obtained for each animal across different time
points, and then the mean ± SE among the animals was
determined. Four to eight rats were included for each
group for quantification of the results. All measurements
were performed by blinded evaluators. Data were com-
pared with student's t-test or one-way ANOVA followed
by Neuman-Keuls tests. P < 0.05 was considered signifi-
cant.
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